Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackson Orem

Showing results (91-100 of 159) with videos related to

Pageof 16
Sort By:
African Health Sciences|August 29, 2022
Turnaround time and barriers to treatment of newly diagnosed cancer in Uganda: a mixed-methods longitudinal studySolomon Kibudde, Eve Namisango, Annet Nakaganda, et al.
Journal of Global Oncology|September 23, 2018
Association Between HIV Infection and Cancer Stage at Presentation at the Uganda Cancer InstituteManoj P Menon, Anna Coghill, Innocent O Mutyaba, et al.
Plos One|February 7, 2019
How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan AfricaHenry Ddungu, Elizabeth M Krantz, Isaac Kajja, et al.
Plos Pathogens|December 18, 2018
Quantitative RNAseq analysis of Ugandan KS tumors reveals KSHV gene expression dominated by transcription from the LTd downstream latency promoterTimothy M Rose, A Gregory Bruce, Serge Barcy, et al.
Scientific Reports|February 20, 2020
Transfusion Challenges in Patients with Hematological Malignancies in Sub-Saharan Africa: A Prospective Observational Study from the Uganda Cancer InstituteHenry Ddungu, Elizabeth M Krantz, Isaac Kajja, et al.
African Health Sciences|August 16, 2021
Characteristics and outcomes of patients with multiple myeloma at the Uganda Cancer InstituteClement D Okello, Yusuf Mulumba, Abrahams Omoding, et al.
PLOS Global Public Health|July 21, 2025
Assessing differences in healthcare access by HIV status to inform cervical cancer and HIV screening in rural UgandaMia Sheehan, Hallie Dau, Maryam AboMoslim, et al.
BMC Cancer|April 11, 2024
Baseline knowledge on risk factors, symptoms and intended behavior of women and men towards screening and treatment of cervical cancer in rural Uganda: a cross-sectional studyCarolyn Nakisige, Marlieke de Fouw, Miriam Nakalembe, et al.
Future Oncology (London, England)|April 15, 2021
Increasing access to quality anticancer medicines in low- and middle-income countries: the experience of UgandaGodfrey Osinde, Nixon Niyonzima, Vivienne Mulema, et al.
The Journal of Infectious Diseases|October 22, 2015
Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in UgandaWarren Phipps, Edith Nakku-Joloba, Elizabeth M Krantz, et al.
Pageof 16

Showing results (91-100 of 159) with videos related to

Sort By:
Pageof 16
African Health Sciences|August 29, 2022
Turnaround time and barriers to treatment of newly diagnosed cancer in Uganda: a mixed-methods longitudinal studySolomon Kibudde, Eve Namisango, Annet Nakaganda, et al.
Journal of Global Oncology|September 23, 2018
Association Between HIV Infection and Cancer Stage at Presentation at the Uganda Cancer InstituteManoj P Menon, Anna Coghill, Innocent O Mutyaba, et al.
Plos One|February 7, 2019
How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan AfricaHenry Ddungu, Elizabeth M Krantz, Isaac Kajja, et al.
Plos Pathogens|December 18, 2018
Quantitative RNAseq analysis of Ugandan KS tumors reveals KSHV gene expression dominated by transcription from the LTd downstream latency promoterTimothy M Rose, A Gregory Bruce, Serge Barcy, et al.
Scientific Reports|February 20, 2020
Transfusion Challenges in Patients with Hematological Malignancies in Sub-Saharan Africa: A Prospective Observational Study from the Uganda Cancer InstituteHenry Ddungu, Elizabeth M Krantz, Isaac Kajja, et al.
African Health Sciences|August 16, 2021
Characteristics and outcomes of patients with multiple myeloma at the Uganda Cancer InstituteClement D Okello, Yusuf Mulumba, Abrahams Omoding, et al.
PLOS Global Public Health|July 21, 2025
Assessing differences in healthcare access by HIV status to inform cervical cancer and HIV screening in rural UgandaMia Sheehan, Hallie Dau, Maryam AboMoslim, et al.
BMC Cancer|April 11, 2024
Baseline knowledge on risk factors, symptoms and intended behavior of women and men towards screening and treatment of cervical cancer in rural Uganda: a cross-sectional studyCarolyn Nakisige, Marlieke de Fouw, Miriam Nakalembe, et al.
Future Oncology (London, England)|April 15, 2021
Increasing access to quality anticancer medicines in low- and middle-income countries: the experience of UgandaGodfrey Osinde, Nixon Niyonzima, Vivienne Mulema, et al.
The Journal of Infectious Diseases|October 22, 2015
Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in UgandaWarren Phipps, Edith Nakku-Joloba, Elizabeth M Krantz, et al.
Pageof 16